Literature DB >> 19309638

Hereditary breast and ovarian cancer syndrome.

.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19309638     DOI： 10.1016/j.ygyno.2009.02.017

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  16 in total

1.  American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.

Authors:  Karen H Lu; Marie E Wood; Molly Daniels; Cathy Burke; James Ford; Noah D Kauff; Wendy Kohlmann; Noralane M Lindor; Therese M Mulvey; Linda Robinson; Wendy S Rubinstein; Elena M Stoffel; Carrie Snyder; Sapna Syngal; Janette K Merrill; Dana Swartzberg Wollins; Kevin S Hughes
Journal:  J Clin Oncol       Date:  2014-02-03       Impact factor: 44.544

2.  BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.

Authors:  Danielle S Chun; Brygida Berse; Vickie L Venne; Scott L DuVall; Kelly K Filipski; Michael J Kelley; Laurence J Meyer; Michael S Icardi; Julie A Lynch
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

Review 3.  Genetic tests to identify risk for breast cancer.

Authors:  Julie A Lynch; Vickie Venne; Brygida Berse
Journal:  Semin Oncol Nurs       Date:  2015-02-26       Impact factor: 2.315

4.  Novel nonsense mutation of BRCA2 gene in a Moroccan man with familial breast cancer.

Authors:  Soukaina Guaoua; Ilham Ratbi; Jaber Lyahyai; Siham Chafai El Alaoui; Fatima-Zahra Laarabi; Abdelaziz Sefiani
Journal:  Afr Health Sci       Date:  2014-06       Impact factor: 0.927

5.  Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.

Authors:  Cecelia A Bellcross; Steven Leadbetter; Sharon Hensley Alford; Lucy A Peipins
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-31       Impact factor: 4.254

6.  Accuracy of ovarian and colon cancer risk assessments by U.S. physicians.

Authors:  Laura-Mae Baldwin; Katrina F Trivers; C Holly A Andrilla; Barbara Matthews; Jacqueline W Miller; Denise M Lishner; Barbara A Goff
Journal:  J Gen Intern Med       Date:  2014-02-12       Impact factor: 5.128

7.  Genetic testing and first presymptomatic diagnosis in Moroccan families at high risk for breast/ovarian cancer.

Authors:  Fatima Zahra Laarabi; Imane Cherkaoui Jaouad; Karim Ouldim; Nisrine Aboussair; Abdelouahed Jalil; Brahim El Khalil El Gueddari; Noureddine Benjaafar; Abdelaziz Sefiani
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

8.  NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

Authors:  Janice L Berliner; Angela Musial Fay; Shelly A Cummings; Brittany Burnett; Todd Tillmanns
Journal:  J Genet Couns       Date:  2012-11-28       Impact factor: 2.537

9.  Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.

Authors:  Merete Bjørnslett; Stian Knappskog; Per Eystein Lønning; Anne Dørum
Journal:  BMC Cancer       Date:  2012-10-05       Impact factor: 4.430

10.  Methodological quality of English-language genetic guidelines on hereditary breast-cancer screening and management: an evaluation using the AGREE instrument.

Authors:  Benedetto Simone; Emma De Feo; Nicola Nicolotti; Walter Ricciardi; Stefania Boccia
Journal:  BMC Med       Date:  2012-11-21       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.